ARDXHealthcarePharma — Specialty·Sep 3, 2026·1 min read

ARDX: FY25 Deep Dive

Ardelyx FY25 at $407M. NI $-62M; EPS $-0.26.

FY25 revenue $407M; OI $-41M; NI $-62M; EPS $-0.26.

Ardelyx FY25 (Dec 31, 2025) at $407M revenue. OpInc $-41M; NI $-62M; EPS $-0.26. Pharma — Specialty.

Related:ARDX

Want deeper analysis?

Ask drillr anything about ARDX — powered by SEC filings, earnings calls, and real-time data.